A new non­prof­it wants to de­sign cheap drug tri­als, aim­ing to build on mas­sive­ly suc­cess­ful Covid-19 study

The UK’s RE­COV­ERY tri­al, a plat­form study eval­u­at­ing sev­er­al po­ten­tial treat­ments for Covid-19 us­ing the NHS’ net­work of hos­pi­tals, has proven one of the most suc­cess­ful pan­dem­ic en­deav­ors, like­ly sav­ing hun­dreds of thou­sands of lives. Its cre­ators want to tack­le oth­er dis­eases in a sim­i­lar man­ner, and they’ve se­cured some Big Phar­ma cash to get start­ed.

Led by RE­COV­ERY mas­ter­mind Mar­tin Lan­dray, the non­prof­it Pro­tas launched Mon­day with $6.8 mil­lion from Sanofi. The goal is to de­sign and de­vel­op cost-ef­fec­tive large scale clin­i­cal tri­als across a wide range of dis­eases, part­ner­ing with phar­ma com­pa­nies, clin­i­cal sites, aca­d­e­m­ic in­sti­tu­tions and pa­tient groups along the way.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER